MEDICAMEQ logo

Medicamen Biotech Limited

MEDICAMEQ·NSE·
266.00 +4.53 (+1.73%)
Market Cap346.77 Cr
PE Ratio37.41
Volume1,35,111
Day High - Low279.00 - 259.05
52W High-Low447.65 - 212.40
DocStoX Score
2.9/10
Poor
Fair Value
Sign in to see
ROE
3.95%
Weak
P/E
37.41x
Expensive
Debt / Equity
0.13
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day259.05
279.00
52W212.40
447.65
DocStoX take

Supported by risk (6.8), but held back by momentum (1.1).

DocStoX score

Low confidence
2.9
/10
Poor
Quality
Weak
ROE 4.0%
Valuation
Expensive
P/E 37.4×
Growth
Flat
Revenue +11.9% 5Y CAGR
Risk
Moderate
D/E 0.13
Momentum
Weak
23% of 52-week range

At a glance

Market Cap
₹347 Cr
52W High / Low
₹448 / ₹212
Dividend Yield
0.43%
Promoter Holding
40.46%
EPS (TTM)
₹7.11
Book Value
₹203.00

Key highlights

  • Low leverage — D/E 0.13
  • Profitable in all of the last 5 years
  • Profit shrinking 4% a year
  • Valuation is weak (1.5/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

MEDICAMEN BIOTECH LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.